GLI1/GLI2 in epithelial to mesenchymal transition triggers vemurafenib-resistance in melanoma (2015)
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Subjects: MELANOMA, CÉLULAS EPITELIAIS, RESISTÊNCIA MICROBIANA ÀS DROGAS
ABNT
FLORES, Fernanda Faião et al. GLI1/GLI2 in epithelial to mesenchymal transition triggers vemurafenib-resistance in melanoma. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 02 nov. 2024. , 2015APA
Flores, F. F., Alves, D. K. M., Pennacchi, P. C., Sandri, S., & Maria-Engler, S. S. (2015). GLI1/GLI2 in epithelial to mesenchymal transition triggers vemurafenib-resistance in melanoma. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Flores FF, Alves DKM, Pennacchi PC, Sandri S, Maria-Engler SS. GLI1/GLI2 in epithelial to mesenchymal transition triggers vemurafenib-resistance in melanoma. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51 7 res. FCF010.[citado 2024 nov. 02 ]Vancouver
Flores FF, Alves DKM, Pennacchi PC, Sandri S, Maria-Engler SS. GLI1/GLI2 in epithelial to mesenchymal transition triggers vemurafenib-resistance in melanoma. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51 7 res. FCF010.[citado 2024 nov. 02 ]